Long-Term Efficacy and Safety of Canagliflozin in Type 2 Diabetes: A 52-Week Indian Experience

Citation
Mahapatra H, Khuntia M, Mahapatra L, et al. Diabetes 2019;68(Suppl 1):2349-PUB.